Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-27

Clinical Trial Update: Effect of Intraarticular Injection of Tenoxicam and Hyaluronic Acid Versus Platelet-Rich Plasma and Hyaluronic Acid in Temporomandibular Joint Internal Derangement [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study comparing intraarticular injections of Tenoxicam plus Hyaluronic Acid versus Platelet-Rich Plasma plus Hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyaluronic acid (hyaluronic acid)
  • Platelet-rich plasma (platelet-rich plasma)
  • Tenoxicam (tenoxicam)

Snippet

Sponsor: Mansoura University | Conditions: Temporomandibular Joint Internal Derangement | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING